Screening for activating EGFR mutations in surgically resected nonsmall cell lung cancer
β Scribed by Sriram, K. B.; Tan, M. E.; Savarimuthu, S. M.; Wright, C. M.; Relan, V.; Stockwell, R. E.; Clarke, B. E.; Duhig, E. E.; Yang, I. A.; Bowman, R. V.
- Book ID
- 115491670
- Publisher
- European Respiratory Society
- Year
- 2011
- Tongue
- English
- Weight
- 381 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0903-1936
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND: Somatic mutations in the epidermal growth factor receptor (__EGFR__) are present in βΌ10% of nonsmall cell lung cancers, and higher in neverβsmokers, women, and Asians. Small inβframe deletions in exon 19 (βΌ45%) and L858R mutation in exon 21 (βΌ40%) predict response to tre
## Abstract ## BACKGROUND: Curative treatment of early stage nonsmall cell lung cancer (NSCLC) requires good quality surgical resection (GQR). The degree of compliance with national recommendations for GQR is poorly defined. We sought to quantitatively define the degree of compliance in a consecut